Synchronous Fibromatosis Indistinguishable from Suspected Synchronous Gastrointestinal Stromal Tumor: A Case Report

Authors

  • Anup Chalise Department of Surgery, Nepal Medical College and Teaching Hospital, Attarkhel, Kathmandu, Nepal https://orcid.org/0000-0003-2960-0547
  • Ashish Prasad Rajbhandari Department of Surgery, Nepal Medical College and Teaching Hospital, Attarkhel, Kathmandu, Nepal https://orcid.org/0000-0002-3417-9745
  • Ramesh Dhakhwa Department of Pathology, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, Nepal

DOI:

https://doi.org/10.31729/jnma.6516

Keywords:

case report, desmoid, fibromatosis, immunohistochemistry

Abstract

Desmoid tumors most commonly occur in the anterior abdominal wall in approximately 50% of
cases and are locally aggressive. We describe a case of a 38-year-old lady who was investigated as a
case of gastrointestinal tumor. Post-operative immunohistochemistry staining showed the presence
of a synchronous desmoid in the abdominal wall and proximal ileum. Wide local excision remains
the gold-standard of treatment with pharmacotherapeutics and radiotherapy serving as adjuvant or
palliative treatment options.

Downloads

Published

2021-09-11

How to Cite

Chalise, A., Rajbhandari, A. P., & Dhakhwa, R. (2021). Synchronous Fibromatosis Indistinguishable from Suspected Synchronous Gastrointestinal Stromal Tumor: A Case Report. Journal of Nepal Medical Association, 59(241), 919–921. https://doi.org/10.31729/jnma.6516

Issue

Vol. 59 No. 241 (2021): JNMA: Published Monthly

Section

Case Reports

License

Copyright (c) 2021 Anup Chalise, Ashish Prasad Rajbhandari, Ramesh Dhakhwa

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.

Most read articles by the same author(s)